tiprankstipranks
Esperion (DE:0ET)
STUTTGART:0ET

Esperion (0ET) Stock News & Sentiment

1 Followers
Esperion to Participate in Upcoming May Investor Conferences
PremiumPress Releases
Esperion to Participate in Upcoming May Investor Conferences
5d ago
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
PremiumPress Releases
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
27d ago
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
PremiumPress Releases
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
1M ago
Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
PremiumPress Releases
Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
1M ago
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24
PremiumPress Releases
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24
1M ago
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
PremiumPress Releases
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
1M ago
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
PremiumPress Releases
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
1M ago
More ESPR News >

News Score - Last 7 Days

Neutral
DE:0ET
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:0ET’s Media Buzz Sentiment?
1 articles about DE:0ET were published this week. In an average week, 1.75 articles are published.
    What is DE:0ET’s weekly average amount of articles?
    In an average week, 1.75 articles about DE:0ET are published.
      What is DE:0ET’s News Sentiment?
      50% of articles about DE:0ET were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        NNVCNanoViricides
        OXBDFOxford BioMedica
        BDXBecton Dickinson
        ABUSArbutus Biopharma
        BRKRBruker
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis